Innovation Pharmaceuticals Inc (IPIX)

[steelyeye]

Yes, prestigious article that mentioned defensin Brilacidin by name, and at the end of that same article, in the concluding paragraph, the authors would not have been wrong to insert the name Brilacidin as one of the class of aforementioned defensins, yet again:

2. Conclusion

Defensins act as short cationic broad range immunostimulators to activate innate and adaptive immunity in response to infectious diseases. In respiratory viral infections, defensin abolishes viruses by inhibiting their entry, interfering with replications, and producing interleukins, cytokines, and chemokines. Also, stimulate to down-regulate the receptors essential for viral survival leading to the death of virus particles.

https://www.sciencedirect.com/science/article/pii/S0882401021002023